← Open Payments lookup

BETSY ZILE: Open Payments

NPI 1285989335 · SHERIDAN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$593 in 33 payments from 11 companies in 2025. Trend: 2023 $423 · 2024 $419 · 2025 $593

Food & beverage: $593
CompanyPaymentsAmount
ABBVIE INC.15$241
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$81
Novo Nordisk Inc3$73
GlaxoSmithKline, LLC.3$51
Lilly USA, LLC2$40
PFIZER INC.2$29
Boehringer Ingelheim Pharmaceuticals, Inc.1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21
Kowa Pharmaceuticals America, Inc.1$14
AstraZeneca Pharmaceuticals LP1$13

Products named: UBRELVY, CAPLYTA, QULIPTA, Ozempic, VRAYLAR, TRELEGY ELLIPTA, ZEPBOUND, JARDIANCE.

Industry payments across IN — which companies pay providers there.